$SGRY
Surgery Partners, Inc. Stock $sgry

$sgry Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000163883324000135 Filed on August 06, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$770.4M	$762.1M
YoY Change	14.29%	14.16%
Cost Of Revenue	$569.0M	$560.7M
YoY Change	16.79%	14.03%
Gross Profit	$201.4M	$201.4M
YoY Change	7.76%	14.5%
Gross Profit Margin	26.14%	26.43%
Selling, General & Admin	$53.10M	$62.50M
YoY Change	-8.29%	17.92%
% of Gross Profit	26.37%	31.03%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$50.20M	$34.80M
YoY Change	73.7%	42.62%
% of Gross Profit	24.93%	17.28%
Operating Expenses	$709.5M	$677.3M
YoY Change	19.95%	788.85%
Operating Profit	$60.90M	$84.80M
YoY Change	-26.27%	-14.94%
Interest Expense	-$50.00M	-$51.50M
YoY Change	0.4%	14.19%
% of Operating Profit	-82.1%	-60.73%
Other Income/Expense, Net	$700.0K	-$4.800M
YoY Change	-41.67%	-173.85%
Pretax Income	$10.90M	$33.30M
YoY Change	-66.77%	-33.27%
Income Tax	$4.500M	$4.900M
% Of Pretax Income	41.28%	14.71%
Net Earnings	-$31.70M	-$15.50M
YoY Change	546.94%	-182.01%
Net Earnings / Revenue	-4.11%	-2.03%
Basic Earnings Per Share	-$0.25	-$0.12
Diluted Earnings Per Share	-$0.25	-$0.12
COMMON SHARES
Basic Shares Outstanding	127.1M shares	127.1M shares
Diluted Shares Outstanding	126.2M shares	126.1M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$221.8M	$213.5M
YoY Change	-6.02%	20.35%
Cash & Equivalents	$221.8M	$213.5M
Short-Term Investments
Other Short-Term Assets	$143.9M	$150.0M
YoY Change	96.32%	33.21%
Inventory	$82.00M	$80.90M
Prepaid Expenses	$45.20M	$44.70M
Receivables	$542.9M	$523.4M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$1.036B	$1.013B
YoY Change	18.22%	24.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.302B	$1.273B
YoY Change	9.95%	16.42%
Goodwill	$4.815B	$4.806B
YoY Change	13.43%	13.47%
Intangibles
YoY Change
Long-Term Investments	$214.8M	$227.1M
YoY Change	9.42%	18.16%
Other Assets	$41.10M	$36.00M
YoY Change	-64.99%	-84.6%
Total Long-Term Assets	$6.499B	$6.476B
YoY Change	10.07%	11.46%
TOTAL ASSETS
Total Short-Term Assets	$1.036B	$1.013B
Total Long-Term Assets	$6.499B	$6.476B
Total Assets	$7.534B	$7.489B
YoY Change	11.13%	13.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$170.8M	$174.0M
YoY Change	14.78%	32.32%
Accrued Expenses	$250.0M	$223.4M
YoY Change	12.31%	16.17%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$97.30M	$92.40M
YoY Change	56.68%	42.81%
Total Short-Term Liabilities	$575.2M	$551.8M
YoY Change	14.72%	20.32%
LONG-TERM LIABILITIES
Long-Term Debt	$3.094B	$3.040B
YoY Change	17.2%	21.35%
Other Long-Term Liabilities	$30.30M	$21.10M
YoY Change	-61.6%	-93.91%
Total Long-Term Liabilities	$30.30M	$21.10M
YoY Change	-61.6%	-99.26%
TOTAL LIABILITIES
Total Short-Term Liabilities	$575.2M	$551.8M
Total Long-Term Liabilities	$30.30M	$21.10M
Total Liabilities	$605.5M	$572.9M
YoY Change	4.34%	-87.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$628.8M	-$597.1M
YoY Change	10.67%	6.0%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.897B	$1.952B
YoY Change
Total Liabilities & Shareholders Equity	$7.534B	$7.489B
YoY Change	11.13%	13.11%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	-$31.70M	-$15.50M
YoY Change	546.94%	-182.01%
Depreciation, Depletion And Amortization	$50.20M	$34.80M
YoY Change	73.7%	42.62%
Cash From Operating Activities	$65.20M	$82.80M
YoY Change	-37.67%	58.93%
INVESTING ACTIVITIES
Capital Expenditures	$20.20M	$26.90M
YoY Change	6.88%	4.26%
Acquisitions
YoY Change
Other Investing Activities	-$29.40M	-$217.2M
YoY Change	338.81%	378.41%
Cash From Investing Activities	-$49.60M	-$244.1M
YoY Change	93.75%	242.84%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-7.300M	189.6M
YoY Change	-64.22%	-486.94%
NET CHANGE
Cash From Operating Activities	65.20M	82.80M
Cash From Investing Activities	-49.60M	-244.1M
Cash From Financing Activities	-7.300M	189.6M
Net Change In Cash	8.300M	28.30M
YoY Change	-85.84%	-141.56%
FREE CASH FLOW
Cash From Operating Activities	$65.20M	$82.80M
Capital Expenditures	$20.20M	$26.90M
Free Cash Flow	$45.00M	$55.90M
YoY Change	-47.49%	112.55%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	127123940	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	127123940	shares
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3034500000	usd
CY2024Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	16900000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4900000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-5500000	usd
CY2024Q1	sgry	Non Controlling Interest Acquisitions And Disposals Of Interests Held By Non Controlling Interest Holders Net NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet	16800000	usd
CY2024Q1	us-gaap	Minority Interest Decrease From Distributions To Noncontrolling Interest Holders MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	29700000	usd
	us-gaap	Profit Loss ProfitLoss	52700000	usd
	us-gaap	Profit Loss ProfitLoss	58900000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68500000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58100000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	18700000	usd
	us-gaap	Operating Lease Expense OperatingLeaseExpense	17900000	usd
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-3100000	usd
	sgry	Noncash Interest Income Expense Net NoncashInterestIncomeExpenseNet	-13100000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20000000.0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8800000	usd
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6800000	usd
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-1700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	282900000	usd
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	120300000	usd
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	21400000	usd
CY2024Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	442100000	usd
CY2024Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	1	anesthesia_practice
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47900000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	264600000	usd
	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	43500000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	1500000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	26100000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	48400000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#OtherLiabilitiesCurrent
CY2024Q2	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligationsCurrent
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2024#LongTermDebtAndCapitalLeaseObligations
CY2023Q2	us-gaap	Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
	us-gaap	Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
	us-gaap	Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
CY2024Q2	us-gaap	Oci Cash Flow Hedge Reclassification For Discontinuance Statement Of Income Or Comprehensive Income Extensible Enumeration OciCashFlowHedgeReclassificationForDiscontinuanceStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration	http://fasb.org/us-gaap/2024#InterestIncomeExpenseNonoperatingNet
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5100000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	7600000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11500000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	-200000	usd
	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	800000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	12100000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5100000	usd
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	0	usd
	sgry	Increase Decrease In Medicare Accelerated Payments And Deferred Governmental Grants IncreaseDecreaseInMedicareAcceleratedPaymentsAndDeferredGovernmentalGrants	-1200000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	47100000	usd
	us-gaap	Increase Decrease In Other Operating Capital Net IncreaseDecreaseInOtherOperatingCapitalNet	13300000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	123500000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	126600000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	50100000	usd
	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	1700000	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	4000000.0	usd
	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	18500000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	26000000.0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-327200000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-141900000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	973800000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	31500000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	1295400000	usd
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	26500000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	14900000	usd
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	1400000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	80700000	usd
	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	76900000	usd
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	1000000.0	usd
	us-gaap	Proceeds From Payments To Minority Shareholders ProceedsFromPaymentsToMinorityShareholders	600000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-5700000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-7500000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	221300000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-90200000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17600000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-105500000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	195900000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	213500000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177400000	usd
CY2024Q2	sgry	Number Of Surgical Facilities Owned NumberOfSurgicalFacilitiesOwned	167	facility
CY2024Q2	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	33	state
CY2024Q2	sgry	Number Of Surgical Facilities Owned Majority Interest NumberOfSurgicalFacilitiesOwnedMajorityInterest	92	facility
CY2024Q2	sgry	Number Of Surgical Facilities Owned Consolidated NumberOfSurgicalFacilitiesOwnedConsolidated	127	facility
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	Certain prior year amounts have been reclassified to conform with the current year presentation.
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and footnotes. Examples include, but are not limited to, estimates of accounts receivable allowances, professional and general liabilities and the estimate of deferred tax assets or liabilities. Actual results could differ from those estimates.</span></div>
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	762100000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	667600000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1479500000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1333800000	usd
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.150
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.190
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	600000	usd
	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Amount EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount	-1800000	usd
	us-gaap	Income Tax Reconciliation Disposition Of Business IncomeTaxReconciliationDispositionOfBusiness	-15900000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4326000000	usd
	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	486300000	usd
	us-gaap	Goodwill Written Off Related To Sale Of Business Unit GoodwillWrittenOffRelatedToSaleOfBusinessUnit	6000000.0	usd
CY2024Q2	us-gaap	Goodwill Goodwill	4806300000	usd
CY2023Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	327400000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	342000000.0	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	15800000	usd
	us-gaap	Net Income Loss Attributable To Redeemable Noncontrolling Interest NetIncomeLossAttributableToRedeemableNoncontrollingInterest	19000000.0	usd
	sgry	Redeemable Noncontrolling Interest Increase Decrease From Redemptions Or Purchase Of Interests RedeemableNoncontrollingInterestIncreaseDecreaseFromRedemptionsOrPurchaseOfInterests	-10000000.0	usd
	sgry	Redeemable Noncontrolling Interest Decrease From Distributions To Noncontrolling Interest Holders RedeemableNoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHolders	22900000	usd
CY2023Q2	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	328100000	usd
CY2024Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	9	facility
CY2024Q2	sgry	Variable Interest Entity Number Of Facilities VariableInterestEntityNumberOfFacilities	18	physician_practice
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	712600000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	693600000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	35000000.0	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	27100000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	3132100000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Including Current Maturities LongTermDebtAndCapitalLeaseObligationsIncludingCurrentMaturities	2775100000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	92400000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	73300000	usd
CY2024Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	3039700000	usd
CY2023Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	2701800000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5100000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	266900000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	255300000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	594600000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	587000000.0	usd
CY2024Q2	sgry	Lease Right Of Use Asset LeaseRightOfUseAsset	861500000	usd
CY2023Q4	sgry	Lease Right Of Use Asset LeaseRightOfUseAsset	842300000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37600000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	257600000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	248900000	usd
CY2024Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	296900000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	286500000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	28500000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	25400000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	684100000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	668200000	usd
CY2024Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	712600000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	693600000	usd
CY2024Q2	sgry	Lease Liability LeaseLiability	1009500000	usd
CY2023Q4	sgry	Lease Liability LeaseLiability	980100000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	32300000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	33200000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	23600000	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	18300000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	26700000	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	23800000	usd
	sgry	Finance Lease Cost FinanceLeaseCost	50300000	usd
	sgry	Finance Lease Cost FinanceLeaseCost	42100000	usd
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	11800000	usd
	sgry	Variable And Short Term Lease Cost VariableAndShortTermLeaseCost	10400000	usd
	us-gaap	Lease Cost LeaseCost	94400000	usd
	us-gaap	Lease Cost LeaseCost	85700000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	31300000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	32200000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	25400000	usd
	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	22600000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15400000	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	12600000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	38000000.0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	15100000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	21200000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	23600000	usd
CY2024Q2	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	2741900000	usd
CY2023Q4	us-gaap	Derivative Notional Amount DerivativeNotionalAmount	1360100000	usd
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	39100000	usd
CY2024Q2	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	40300000	usd
CY2024Q2	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	14100000	usd
CY2023Q4	us-gaap	Derivative Asset Notional Amount DerivativeAssetNotionalAmount	57400000	usd
CY2023Q4	us-gaap	Derivative Liability Notional Amount DerivativeLiabilityNotionalAmount	17800000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	5300000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	10700000	usd
CY2024Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	0	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Reclassification For Discontinuance Before Tax OtherComprehensiveIncomeLossCashFlowHedgeReclassificationForDiscontinuanceBeforeTax	0	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-15500000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	18900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-27900000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-6000000.0	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126134000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125718000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	126053000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	125463000	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126134000	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127370000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	126053000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	125463000	shares
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.15
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.22
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.05
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.12
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.15
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.05
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	39300000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	37600000	usd
CY2024Q2	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	21300000	usd
CY2023Q4	sgry	Cost Report Liabilities Current CostReportLiabilitiesCurrent	23900000	usd
CY2024Q2	srt	Payables To Customers PayablesToCustomers	30000000.0	usd
CY2023Q4	srt	Payables To Customers PayablesToCustomers	23900000	usd
CY2024Q2	us-gaap	Interest Payable Current InterestPayableCurrent	16700000	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	17800000	usd
CY2024Q2	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	10700000	usd
CY2023Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	0	usd
CY2024Q2	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	104300000	usd
CY2023Q4	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	100900000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	222300000	usd
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	204100000	usd
CY2024Q2	us-gaap	Self Insurance Reserve SelfInsuranceReserve	18300000	usd
CY2023Q4	us-gaap	Self Insurance Reserve SelfInsuranceReserve	18200000	usd
CY2023Q4	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10200000	usd
CY2024Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	10200000	usd
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	2	segment
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	762100000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	667600000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1479500000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1333800000	usd
CY2024Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	118300000	usd
CY2023Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	100200000	usd
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	215800000	usd
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	190300000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	33300000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	49900000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	62000000.0	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	49500000	usd
CY2024Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	43900000	usd
CY2023Q2	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	38800000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	80600000	usd
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	64900000	usd
CY2024Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-51500000	usd
CY2023Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-47700000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-98800000	usd
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-94500000	usd
CY2024Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	34800000	usd
CY2023Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	24400000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	68500000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58100000	usd
CY2024Q2	us-gaap	Share Based Compensation ShareBasedCompensation	15100000	usd
CY2023Q2	us-gaap	Share Based Compensation ShareBasedCompensation	4600000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	20000000.0	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	8800000	usd
CY2024Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	20800000	usd
CY2023Q2	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	13000000.0	usd
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	39700000	usd
	sgry	Business Combination Integration Related Costs And Merger Costs BusinessCombinationIntegrationRelatedCostsAndMergerCosts	25800000	usd
CY2024Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-5300000	usd
CY2023Q2	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	8800000	usd
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-6800000	usd
	sgry	Gain Loss On Disposition Of Assets And Deconsolidation GainLossOnDispositionOfAssetsAndDeconsolidation	-1700000	usd
CY2024Q2	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	-1100000	usd
CY2023Q2	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	-1700000	usd
	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	100000	usd
	sgry	Gain Loss Related To Litigation Settlement And Regulatory Change Impact GainLossRelatedToLitigationSettlementAndRegulatoryChangeImpact	-9700000	usd
CY2024Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5100000	usd
CY2023Q2	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-5100000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
CY2024Q2	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	0	usd
CY2023Q2	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	0	usd
	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	0	usd
	sgry	Undesignated Derivative Activity UndesignatedDerivativeActivity	-600000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4800000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6500000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4400000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	6500000	usd
CY2023Q2	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	100200000	usd
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	215800000	usd
	sgry	Earnings Before Interest Taxes Depreciation And Amortization EarningsBeforeInterestTaxesDepreciationAndAmortization	190300000	usd
CY2024Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	19300000	usd
CY2023Q2	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	12000000.0	usd
CY2024Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1500000	usd
CY2023Q2	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1000000.0	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	36700000	usd
	us-gaap	Business Combination Integration Related Costs BusinessCombinationIntegrationRelatedCosts	24500000	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	3000000.0	usd
	us-gaap	Business Combination Acquisition Related Costs BusinessCombinationAcquisitionRelatedCosts	1300000	usd
CY2024Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-500000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-1500000	usd
CY2024Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	600000	usd
CY2023Q2	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	200000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	1300000	usd
	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-4500000	usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	1200000	usd
	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	800000	usd
	sgry	Interest Expense Impact Of Change In Letter Of Protection Regulation InterestExpenseImpactOfChangeInLetterOfProtectionRegulation	4400000	usd
CY2024Q2	us-gaap	Assets Assets	7488600000	usd
CY2023Q4	us-gaap	Assets Assets	6876700000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	47900000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	50100000	usd
CY2024Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001638833-24-000135-index-headers.html	Edgar Link	pending
0001638833-24-000135-index.html	Edgar Link	pending
0001638833-24-000135.txt	Edgar Link	pending
0001638833-24-000135-xbrl.zip	Edgar Link	pending
a2024q2exhibit103.htm	Edgar Link	pending
a2024q2exhibit104.htm	Edgar Link	pending
a2024q2exhibit311.htm	Edgar Link	pending
a2024q2exhibit312.htm	Edgar Link	pending
a2024q2exhibit321.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sgry-20240630.htm	Edgar Link	pending
sgry-20240630.xsd	Edgar Link	pending
sgry-20240630_g1.jpg	Edgar Link	pending
Show.js	Edgar Link	pending
sgry-20240630_def.xml	Edgar Link	unprocessable
sgry-20240630_lab.xml	Edgar Link	unprocessable
sgry-20240630_pre.xml	Edgar Link	unprocessable
sgry-20240630_htm.xml	Edgar Link	completed
FilingSummary.xml	Edgar Link	unprocessable
sgry-20240630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SGRY
Surgery Partners, Inc. Stock $sgry

2024 Q3 Form 10-Q Financial Statement

#000163883324000135 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY Surgery Partners, Inc. Stock $sgry

2024 Q3 Form 10-Q Financial Statement

#000163883324000135 Filed on August 06, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SGRY
Surgery Partners, Inc. Stock $sgry